Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: an equilibrium approach. - Philipp T. Meyer; David Elmenhorst; Dirk Bier; Marcus H. Holschbach; Andreas Matusch; Heinz H. Coenen; Karl Zilles; Andreas Bauer 005 (NeuroImage, 2005)

A1 adenosine receptor PET using [18F]CPFPX: Displacement studies in humans. - Philipp T. Meyer; David Elmenhorst; Andreas Matusch; Oliver H. Winz; Karl Zilles; Andreas Bauer 005 (NeuroImage, 2006)

Test-retest stability of cerebral mGluR5 quantification using [11C]ABP688 and PET in rats. - David Elmenhorst; Antonio Aliaga; Andreas Bauer 005; Pedro Rosa-Neto (NeuroImage, 2010)

Comparison of [18F]CPFPX in vivo PET imaging and [3H]CPFPX in vitro saturation binding assays. - Tina Kroll; David Elmenhorst; Valentina Garibotto; Andreas Bauer 005 (NeuroImage, 2010)

Cerebral A1 adenosine receptor availability in female and male participants and its relationship to sleep. - Anna L. Pierling; Eva-Maria Elmenhorst; Denise Lange; Eva Hennecke; Diego M. Baur; Simone Beer; Tina Kroll; Bernd Neumaier; Daniel Aeschbach; Andreas Bauer 005; Hans-Peter Landolt; David Elmenhorst (NeuroImage, 2021)

A genetic variation in the adenosine A2A receptor gene contributes to variability in oscillatory alpha power in wake and sleep EEG and A1 adenosine receptor availability in the human brain. - Naemi L. Tichelman; Anna L. Foerges; Eva-Maria Elmenhorst; Denise Lange; Eva Hennecke; Diego M. Baur; Simone Beer; Tina Kroll; Bernd Neumaier; Andreas Bauer 005; Hans-Peter Landolt; Daniel Aeschbach; et al. (NeuroImage, 2023)